LifeStance Health (LFST)
Nasdaq Market Closed
LifeStance Health Group, Inc. is a US-based provider of outpatient behavioral healthcare services. The company connects patients with licensed clinicians across psychiatry, psychology, and therapy, offering care for conditions such as anxiety, depression, bipolar disorder, post-traumatic stress disorder, eating disorders, and other mental health needs. Its services include psychiatric evaluations, medication management, psychological and neuropsychological testing, and individual, family, and group therapy.
LifeStance operates in a market shaped by rising demand for mental health treatment, broader insurance coverage, and growing acceptance of virtual care. The company’s model combines in-person clinics with telehealth appointments, giving patients flexibility while allowing clinicians to serve a wider geographic base. It works with adults, children, adolescents, couples, and families, and its care delivery is built around evidence-based treatment approaches.
The business is organized as a single operating segment focused on mental health services. LifeStance typically contracts with commercial insurers and other payers, positioning itself as an accessible alternative to cash-pay-only therapy practices. This insurance-based model is central to its strategy because affordability and network participation are important barriers in behavioral healthcare.
As a listed healthcare company, LifeStance is closely tied to trends in clinician recruitment and retention, reimbursement rates, patient utilization, and the integration of digital health tools into traditional care settings. Its scale, clinical network, and hybrid delivery platform distinguish it from smaller local practices, while its focus remains concentrated on outpatient mental health rather than broader hospital or primary care services.
Last updated
- Market Cap
- 2.86B
- P/E
- 123.45
- P/FCF
- 20.08
- P/S
- 1.92
- Enterprise Value
- 2.93B
- Sector
- —
- Industry
- —
- Address
- 4800 N. SCOTTSDALE ROAD, SCOTTSDALE, AZ, 85251
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Reports First Quarter 2026 Results
Emotional Counseling Service Market Report 2026-2035: A $21.21 Billion Industry by 2030 with Cleveland Clinic, Teladoc Health., LifeStance, GoodRx, Thriveworks, Headspace, Lyra Health, MDLive Leading
Grief Counselling Market Report 2026-2035: A $5.83 Billion Industry by 2030 with Cleveland Clinic, LifeStance Health, VITAS Healthcare, and Talkspace Leading
Presidio Appoints Paula Cipollone Chief Transformation Officer
LifeStance Reports First Quarter 2025 Results
LifeStance Reports Fourth Quarter and Full Year 2024 Results
Lifeist Explores Legal Options Regarding Hedge Fund Settlement
Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)
Mikra Completes Design of New Product and Advances Shipment Date
LifeStance to Participate in Upcoming Investor Conferences
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health Group Announces Launch of Secondary Public Offering
Lifeist Announces TSXV Approval of Common Share Consolidation
LifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue Estimates
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
LifeStance Reports First Quarter 2024 Results
RadNet (RDNT) Q1 Earnings and Revenues Surpass Estimates
Lifeist Announces Common Share Consolidation
Lifeist Reports First Quarter 2024 Financial Results
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 2.86B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 2.93B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 123.45
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.94
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.92
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 29.82
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.96
- EPS
- 0.06
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 20.08
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 15.7
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 142.63M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 1.57%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.08%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.18
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.48
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.48
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.81
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 6.08M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 7.5
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 403.48M | 382.2M | 363.81M | 345.31M | 332.97M |
| Gross profit | 135.93M | 126.3M | 116.58M | 108.43M | 109.79M |
| Operating income | 21.56M | 17.96M | 7.41M | -2.95M | 1.6M |
| EBITDA | 34.88M | 31.4M | 20.97M | 11.06M | 15.36M |
| Net income | 14.24M | 11.67M | 1.08M | -3.79M | 709K |
| Basic EPS | 0.04 | 0.04 | — | -0.01 | — |
| Diluted EPS | 0.04 | 0.03 | — | -0.01 | — |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2.15B | 2.2B | 2.15B | 2.15B | 2.1B |
| Total liabilities | 668.47M | 682.92M | 656.23M | 672.88M | 647.57M |
| Total equity | 1.48B | 1.52B | 1.49B | 1.47B | 1.46B |
| Cash & equivalents | 194.8M | 248.64M | 203.9M | 188.93M | 134.34M |
| Current assets | 355.91M | 416.2M | 360.38M | 358.85M | 304.63M |
| Current liabilities | 239.73M | 251.96M | 228.56M | 242.29M | 207.39M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 33.11M | 57.56M | 27.29M | 64.4M | -3.09M |
| Investing cash flow | -13.91M | -10.91M | -10.29M | -7.76M | -7.17M |
| Financing cash flow | -73.04M | -1.91M | -2.02M | -2.05M | -9.98M |
| Change in cash | -53.85M | 44.74M | 14.97M | 54.59M | -20.24M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G/A — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 8-K — LifeStance Health Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — BLACK DARREN M. | View Filing | |
| form 4 | Form 4 — Shuey Eric | View Filing | |
| form 4 | Form 4 — Shuey Eric | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — COULTER JAMES G | View Filing | |
| form 4 | Form 4 — TPG GP A, LLC | View Filing | |
| form 4 | Form 4 — WINKELRIED JON | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 424B7 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 424B7 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 8-K — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 10-Q — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 144 — LifeStance Health Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| edgar index | SCHEDULE 13G/A — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 144 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 144 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| edgar index | DEF 14A — LifeStance Health Group, Inc. | View Filing | |
| edgar index | DEFA14A — LifeStance Health Group, Inc. | View Filing | |
| edgar index | ARS — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 144 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| form 4 | Form 4 — Bessler Robert | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — Pardo Ryan | View Filing | |
| form 4 | Form 4 — Pardo Ryan | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — McGroarty Ryan | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — McGroarty Ryan | View Filing | |
| edgar index | 8-K — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| edgar index | 4 — LifeStance Health Group, Inc. | View Filing | |
| form 4 | Form 4 — Paunovich Vukasin | View Filing | |
| form 4 | Form 4 — Paunovich Vukasin | View Filing | |
| form 4 | Form 4 — McGroarty Ryan | View Filing |